Effects of chronic fluoxetine treatment on serotonin 1B receptor-induced deficits in delayed alternation

Psychopharmacology

Volumn 227, Issue 3, 2013, Pages 545-551

  Woehrle, Nancy S ^a,c   Klenotich, Stephanie J ^b   Jamnia, Naseem ^c   Ho, Emily V ^c   Dulawa, Stephanie C ^b,c  

^a WITTENBERG UNIVERSITY   (United States)

^b Committee on Neurobiology ^*  (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Delayed alternation task; Mice; Serotonin 1B receptor; Serotonin reuptake inhibitors; Serotonin transporter

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; FLUOXETINE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; SEROTONIN 1B RECEPTOR; SODIUM CHLORIDE;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RECEPTOR BINDING; FEMALE; LATENT PERIOD; LONG TERM CARE; MEMORY DISORDER; MOUSE; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; ORBITAL CORTEX; PRIORITY JOURNAL; WORKING MEMORY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOXETINE; FRONTAL LOBE; MAZE LEARNING; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; OBSESSIVE-COMPULSIVE DISORDER; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SEROTONIN UPTAKE INHIBITORS; TASK PERFORMANCE AND ANALYSIS; TIME FACTORS;

EID: 84878108369     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-2985-0     Document Type: Article

References (42)

1. Abbruzzese M, Bellodi L, Ferri S, Scarone S (1995) Frontal lobe dysfunction in schizophrenia and obsessive-compulsive disorder: a neuropsychological study. Brain Cogn 27:202-212
2. Abbruzzese M, Ferri S, Scarone S (1997) The selective breakdown of frontal functions in patients with obsessive-compulsive disorder and in patients with schizophrenia: a double dissociation experimental finding. Neuropsychologia 35:907-912
3. Andersen SL, Greene-Colozzi EA, Sonntag KC (2010) A novel, multiple symptom model of obsessive-compulsive-like behaviors in animals. Biol Psychiatry 68:741-747
4. Baxter LR Jr, Schwartz JM, Mazziotta JC, Phelps ME, Pahl JJ, Guze BH, Fairbanks L (1988) Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry 145:1560-1563
5. Benkelfat C, Nordahl TE, Semple WE, King AC, Murphy DL, Cohen RM (1990) Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. Arch Gen Psychiatry 47:840-848
6. Breiter HC, Rauch SL, Kwong KK, Baker JR, Weisskoff RM, Kennedy DN, Kendrick AD et al (1996) Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry 53:595-606
7. Butters N, Rosvold HE (1968) Effect of caudate and septal nuclei lesions on resistance to extinction and delayed-alternation. J Comp Physiol Psychol 65:397-403
8. Chamberlain SR, Fineberg NA, Menzies LA, Blackwell AD, Bullmore ET, Robbins TW, Sahakian BJ (2007) Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry 164:335-338
9. Cottraux J, Gerard D, Cinotti L, Froment JC, Deiber MP, Le Bars D, Galy G et al (1996) A controlled positron emission tomography study of obsessive and neutral auditory stimulation in obsessive-compulsive disorder with checking rituals. Psychiatry Res 60:101-112
10. Dulawa SC, Gross C, Stark KL, Hen R, Geyer MA (2000) Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition. Neuropsychopharmacology 22:650-659
11. Dulawa SC, Holick KA, Gundersen B, Hen R (2004) Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29:1321-1330
12. El Mansari M, Blier P (2005) Responsiveness of 5-HT(1A) and 5-HT2 receptors in the rat orbitofrontal cortex after long-term serotonin reuptake inhibition. J Psychiatry NeuroSci 30:268-274
13. Freedman M, Black S, Ebert P, Binns M (1998) Orbitofrontal function, object alternation and perseveration. Cereb Cortex 8:18-27
14. Freedman M, Oscar-Berman M (1986) Bilateral frontal lobe disease and selective delayed response deficits in humans. Behav Neurosci 100:337-342
15. Gagliardo A, Bonadonna F, Divac I (1996) Behavioural effects of ablations of the presumed 'prefrontal cortex' or the corticoid in pigeons. Behav Brain Res 78:155-162
16. Glennon RA, Dukat M, Westkaemper RB American College of Neuropsychopharmacology (2000) Psychopharmacology: the fourth generation of progress. Raven Press, New York
17. Goldman-Rakic P (1987) Circuitry of the primate prefrontal cortex and the regulation of behavior by representational memory. Handbook of physiology, the nervous system, higher functions of the brain. Plum F (ed). Bethesda, MD, American Physiological Society. V:373-417
18. Goldman PS, Rosvold HE, Mishkin M (1970) Evidence for behavioral impairment following prefrontal lobectomy in the infant monkey. J Comp Physiol Psychol 70:454-463
19. Green AR, Guy AP, Gardner CR (1984) The behavioural effects of RU 24969, a suggested 5-HT1 receptor agonist in rodents and the effect on the behaviour of treatment with antidepressants. Neuropharmacology 23:655-661
20. Gross-Isseroff R, Cohen R, Sasson Y, Voet H, Zohar J (2004) Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan. Neuropsychobiology 50:200-205
21. Gross-Isseroff R, Sasson Y, Voet H, Hendler T, Luca-Haimovici K, Kandel-Sussman H, Zohar J (1996) Alternation learning in obsessive-compulsive disorder. Biol Psychiatry 39:733-738
22. Hervas I, Vilaro MT, Romero L, Scorza MC, Mengod G, Artigas F (2001) Desensitization of 5-HT(1A) autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635. Neuropsychopharmacology 24:11-20
23. Koran LM, Pallanti S, Quercioli L (2001) Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder. Eur Neuropsychopharmacol 11:169-172
24. Markowitsch HJ, Pritzel M, Kessler J, Guldin W, Freeman RB Jr (1980) Delayed-alternation performance after selective lesions within the prefrontal cortex of the cat. Behav Brain Res 1:67-91
25. Moritz S, Fricke S, Wagner M, Hand I (2001) Further evidence for delayed alternation deficits in obsessive-compulsive disorder. J Nerv Ment Dis 189:562-564
26. Moritz S, Hottenrott B, Randjbar S, Klinge R, Von Eckstaedt FV, Lincoln TM, Jelinek L (2009) Perseveration and not strategic deficits underlie delayed alternation impairment in obsessive-compulsive disorder (OCD). Psychiatry Res 170:66-69
27. Nordahl TE, Benkelfat C, Semple WE, Gross M, King AC, Cohen RM (1989) Cerebral glucose metabolic rates in obsessive compulsive disorder. Neuropsychopharmacology 2:23-28
28. Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Tolliver TJ, Murphy DL (1990) Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results. Arch Gen Psychiatry 47:926-932
29. Rao NP, Reddy YC, Kumar KJ, Kandavel T, Chandrashekar CR (2008) Are neuropsychological deficits trait markers in ocd? Prog Neuropsychopharmacol Biol Psychiatry 32:1574-1579
30. Remijnse PL, Nielen MM, van Balkom AJ, Cath DC, van Oppen P, Uylings HB, Veltman DJ (2006) Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder. Arch Gen Psychiatry 63:1225-1236
31. Remijnse PL, Nielen MM, van Balkom AJ, Hendriks GJ, Hoogendijk WJ, Uylings HB, Veltman DJ (2009) Differential frontal-striatal and paralimbic activity during reversal learning in major depressive disorder and obsessive-compulsive disorder. Psychol Med 39:1503-1518
32. Roth RM, Baribeau J, Milovan DL, O'Connor K (2004) Speed and accuracy on tests of executive function in obsessive-compulsive disorder. Brain Cogn 54:263-265
33. Saxena S, Brody AL, Maidment KM, Dunkin JJ, Colgan M, Alborzian S, Phelps ME et al (1999) Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology 21:683-693
34. Shanahan NA, Holick Pierz KA, Masten VL, Waeber C, Ansorge M, Gingrich JA, Geyer MA et al (2009) Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice. Biol Psychiatry 65:401-408
35. Shanahan NA, Velez LP, Masten VL, Dulawa SC (2011) Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice. Biol Psychiatry 70:1039-1048
36. Stein DJ, Van Heerden B, Wessels CJ, Van Kradenburg J, Warwick J, Wasserman HJ (1999) Single photon emission computed tomography of the brain with Tc-99 m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin auto-receptor. Prog Neuropsychopharmacol Biol Psychiatry 23:1079-1099
37. Swedo SE, Pietrini P, Leonard HL, Schapiro MB, Rettew DC, Goldberger EL, Rapoport SI et al (1992) Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Arch Gen Psychiatry 49:690-694
38. Swedo SE, Schapiro MB, Grady CL, Cheslow DL, Leonard HL, Kumar A, Friedland R et al (1989) Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry 46:518-523
39. Tollefson GD, Birkett M, Koran L, Genduso L (1994) Continuation treatment of OCD: double-blind and open-label experience with fluoxetine. J Clin Psychiatry 55(Suppl: 69-76):69-76, discussion 77-68
40. Viswanath B, Janardhan Reddy YC, Kumar KJ, Kandavel T, Chandrashekar CR (2009) Cognitive endophenotypes in OCD: a study of unaffected siblings of probands with familial OCD. Prog Neuropsychopharmacol Biol Psychiatry 33:610-615
41. Warren JM, Akert K, University PS (1964) The frontal granular cortex and behavior. McGraw-Hill, New York
42. Zahrt J, Taylor JR, Mathew RG, Arnsten AF (1997) Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17:8528-8535